Kimberly L Desmond1, Hatef Mehrabian1,2, Sofia Chavez3, Arjun Sahgal2,4, Hany Soliman2,4, Radoslaw Rola5, Greg J Stanisz1,2,5. 1. Physical Sciences, Sunnybrook Research Institute, Toronto, Ontario, Canada. 2. Medical Biophysics, University of Toronto, Toronto, Ontario, Canada. 3. Research Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. 4. Radiation Oncology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 5. Department of Neurosurgery and Pediatric Neurosurgery, Medical University, Lublin, Poland.
Abstract
PURPOSE: The purpose of this work was to determine the predictive value of chemical exchange saturation transfer (CEST) metrics in brain metastases treated with stereotactic radiosurgery (SRS). METHODS: CEST spectra at a radiofrequency power of 0.52 µT were collected on a 3 Tesla (T) magnetic resonance imaging from 25 patients at three time points: pretreatment, 1 week, and 1 month post-treatment. Amide proton transfer-weighted images and maps of the amplitude and width of Lorentzian-shaped CEST peaks and the relaxation-compensated AREX metric were constructed at the offset frequencies of amide, amine, and relayed nuclear Overhauser effect (NOE) from aliphatic groups as well as the broad magnetization transfer effect. Pretreatment CEST metrics, as well as CEST metric changes at 1 week post-treatment, were compared to changes in tumor volume at 1 month. RESULTS: Significant (P < 0.05) 1-week predictive metrics included NOE peak amplitude (R = 0.69) in normal-appearing white matter (NAWM) and width (R = -0.55) in tumor. Baseline NOE in contralateral NAWM was negatively correlated (R = -0.69) with volume changes at 1 month. Metrics-defined outside tumor margins had higher correlation with volume changes than tumor regions of interest. CONCLUSION: CEST metrics, in particular, the NOE peak amplitude, can predict volume changes 1 month post-SRS. Magn Reson Med 78:1110-1120, 2017.
PURPOSE: The purpose of this work was to determine the predictive value of chemical exchange saturation transfer (CEST) metrics in brain metastases treated with stereotactic radiosurgery (SRS). METHODS: CEST spectra at a radiofrequency power of 0.52 µT were collected on a 3 Tesla (T) magnetic resonance imaging from 25 patients at three time points: pretreatment, 1 week, and 1 month post-treatment. Amide proton transfer-weighted images and maps of the amplitude and width of Lorentzian-shaped CEST peaks and the relaxation-compensated AREX metric were constructed at the offset frequencies of amide, amine, and relayed nuclear Overhauser effect (NOE) from aliphatic groups as well as the broad magnetization transfer effect. Pretreatment CEST metrics, as well as CEST metric changes at 1 week post-treatment, were compared to changes in tumor volume at 1 month. RESULTS: Significant (P < 0.05) 1-week predictive metrics included NOE peak amplitude (R = 0.69) in normal-appearing white matter (NAWM) and width (R = -0.55) in tumor. Baseline NOE in contralateral NAWM was negatively correlated (R = -0.69) with volume changes at 1 month. Metrics-defined outside tumor margins had higher correlation with volume changes than tumor regions of interest. CONCLUSION: CEST metrics, in particular, the NOE peak amplitude, can predict volume changes 1 month post-SRS. Magn Reson Med 78:1110-1120, 2017.
Authors: Daniel Paech; Constantin Dreher; Sebastian Regnery; Jan-Eric Meissner; Steffen Goerke; Johannes Windschuh; Johanna Oberhollenzer; Miriam Schultheiss; Katerina Deike-Hofmann; Sebastian Bickelhaupt; Alexander Radbruch; Moritz Zaiss; Andreas Unterberg; Wolfgang Wick; Martin Bendszus; Peter Bachert; Mark E Ladd; Heinz-Peter Schlemmer Journal: Eur Radiol Date: 2019-02-26 Impact factor: 5.315
Authors: Andrei Mouraviev; Jay Detsky; Arjun Sahgal; Mark Ruschin; Young K Lee; Irene Karam; Chris Heyn; Greg J Stanisz; Anne L Martel Journal: Neuro Oncol Date: 2020-06-09 Impact factor: 12.300
Authors: John H Suh; Rupesh Kotecha; Samuel T Chao; Manmeet S Ahluwalia; Arjun Sahgal; Eric L Chang Journal: Nat Rev Clin Oncol Date: 2020-02-20 Impact factor: 66.675
Authors: Sebastian Regnery; Sebastian Adeberg; Constantin Dreher; Johanna Oberhollenzer; Jan-Eric Meissner; Steffen Goerke; Johannes Windschuh; Katerina Deike-Hofmann; Sebastian Bickelhaupt; Moritz Zaiss; Alexander Radbruch; Martin Bendszus; Wolfgang Wick; Andreas Unterberg; Stefan Rieken; Jürgen Debus; Peter Bachert; Mark Ladd; Heinz-Peter Schlemmer; Daniel Paech Journal: Oncotarget Date: 2018-06-19